SCHEMBL4673757

SCHEMBL4673757

Nc1ccc(Cc2ccc(C(=O)/C=C(\O)C(=O)O)s2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 4/20 0.35
ITGA5 P08648 4/20 0.35
ALDH1A1 P00352 3/20 0.35
TSHR P16473 2/20 0.35
CYP3A4 P08684 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ITGB3 P05106 3/20 0.34
ITGAV P06756 3/20 0.34
ALOX5 P09917 2/20 0.33
KMT2A Q03164 3/20 0.31
HPGD P15428 3/20 0.31
MEN1 O00255 2/20 0.31
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31
NFKB1 P19838 1/20 0.31
RAB9A P51151 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4673762 1.00 ITGB1 (0.35) ITGB1ITGA5ALDH1A1TSHRCYP3A4
SCHEMBL4673394 0.87 ALOX5 (0.40) ALDH1A1TDP1ALOX5KMT2AHPGD
SCHEMBL4673397 0.87 ALOX5 (0.40) ALDH1A1TDP1ALOX5KMT2AHPGD
SCHEMBL4678283 0.86 ALOX5 (0.40) ALDH1A1TSHRALOX5KMT2AHPGD
SCHEMBL4678282 0.86 ALOX5 (0.40) ALDH1A1TSHRALOX5KMT2AHPGD
SCHEMBL4676027 0.86 MAPT (0.39) ALDH1A1CYP3A4TDP1ALOX5KMT2A
SCHEMBL4676029 0.86 MAPT (0.39) ALDH1A1CYP3A4TDP1ALOX5KMT2A
SCHEMBL4674256 0.84 KMT2A (0.46) ALDH1A1TSHRALOX5KMT2AHPGD
SCHEMBL4674260 0.84 KMT2A (0.46) ALDH1A1TSHRALOX5KMT2AHPGD
SCHEMBL4673330 0.83 TBXAS1 (0.38) ALDH1A1TSHRKMT2AHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142872-B1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO (JP) 2008-10-15 EP disclosed
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6645956-B1 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment SHIONOGI & CO., LTD. (JP) 2003-11-11 US disclosed
US-6620841-B1 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) SHIONOGI & CO., LTD. (JP) 2003-09-16 US disclosed
EP-1142872-A1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO., LTD. (JP) 2001-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 ITGB1 2186/4885ITGA5 4175/4885ALDH1A1 980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.